2021
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites
Mutlu L, Li J, Tymon-Rosario J, Hui P, Menderes G. Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites. Gynecologic Oncology 2021, 162: s113-s114. DOI: 10.1016/s0090-8258(21)00857-x.Peer-Reviewed Original ResearchEarly-stage diseaseHigh-grade histologyOvarian preservationAdjuvant therapyNode dissectionGrade histologyOncologic outcomesClinicopathologic characteristicsMyometrial invasionSarcomatous overgrowthPatients underwent lymph node dissectionUnderwent lymph node dissectionEvidence of diseaseLymph node dissectionNon-inferior outcomesRate of recurrencePractical management optionsCervical adenosarcomaHormonal therapyLast followPositive nodesStage diseasePremenopausal womenMedian ageBetter prognosis
2014
Hormonal Therapy for Aggressive Angiomyxoma
Schwartz PE, Hui P, McCarthy S. Hormonal Therapy for Aggressive Angiomyxoma. Journal Of Lower Genital Tract Disease 2014, 18: e55-e61. PMID: 24402356, DOI: 10.1097/lgt.0b013e3182a22019.Peer-Reviewed Original ResearchConceptsHormonal therapyMenopausal statusAggressive angiomyxomaPatient's menopausal statusRecurrent aggressive angiomyxomaEstrogen receptorRecurrent diseaseLeuprolide acetateProgestin receptor contentInitial surgical resectionExtent of diseaseTreatment of patientsMonthly leuprolideAdjuvant therapyNeoadjuvant therapyPelvic recurrencePostmenopausal womenPremenopausal womenSurgical resectionDefinitive treatmentHormonal agentsReceptor contentSensitive tumorsAromatase inhibitorsProgestin receptors